| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/17/2009 | WO2009113950A1 Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009112832A1 Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009112709A2 Novel method for preparing extracts of ginkgo biloba |
| 09/17/2009 | WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | WO2009112678A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112674A2 Compounds for use in the treatment of neuropathic pain |
| 09/17/2009 | WO2009112652A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112651A1 Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/17/2009 | WO2009112609A1 Novel uses of sodium 4-phenylbutyrate (4 pba) and the pharmaceutically acceptable salts thereof |
| 09/17/2009 | WO2009112568A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors |
| 09/17/2009 | WO2009112541A2 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 09/17/2009 | WO2009112459A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/17/2009 | WO2009112439A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 09/17/2009 | WO2009112395A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | WO2009112139A1 Azaindole compounds for treatment of central nervous system disorders |
| 09/17/2009 | WO2009112033A1 Use of npy y5 receptor antagonists for the prevention of psychostimulant and opioid abuse |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2009111906A1 Beta sheet inhibiting peptides for preventing and/or treating alzheimer's disease |
| 09/17/2009 | WO2009093916A3 Derivatives of aminoalkanols, method of obtaining aminoalkanols and their use |
| 09/17/2009 | WO2009092892A3 Novel composition for treating the side effects of anticancer treatments |
| 09/17/2009 | WO2009086202A3 Methods for treating neuropsychiatric conditions |
| 09/17/2009 | WO2009046867A3 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 09/17/2009 | WO2009046866A3 Trap-14 as a therapeutic agent |
| 09/17/2009 | WO2009044007A3 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 09/17/2009 | WO2009040070A3 Use of helodermin as a therapeutic agent |
| 09/17/2009 | WO2008076946A9 Methods of neuroprotection by cyclin-dependent kinase inhibition |
| 09/17/2009 | WO2007135241A3 Composition and method for binding acetaldehyde in stomach |
| 09/17/2009 | WO2003007876A3 N-fatty acid-amino acid conjugates and therapeutic uses |
| 09/17/2009 | US20090234021 Treatment of Demyelinating Conditions |
| 09/17/2009 | US20090234020 Processes for the preparation of odesmethylvenlafaxine, free from its dimer impurities |
| 09/17/2009 | US20090234003 Carbamate compounds for use in preventing or treating anxiety disorders |
| 09/17/2009 | US20090234001 Vitamin d receptor modulators |
| 09/17/2009 | US20090233994 Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use |
| 09/17/2009 | US20090233993 Compositions and methods for inhibiting gsk3 activity and uses thereof |
| 09/17/2009 | US20090233978 Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders |
| 09/17/2009 | US20090233971 GSK-3 Inhibitors |
| 09/17/2009 | US20090233970 Combined nsaid and acid blocker formulation and method |
| 09/17/2009 | US20090233959 Beloxepin and analogs for the treatment of pain |
| 09/17/2009 | US20090233958 (+)-beloxepin and methods for its synthesis and use |
| 09/17/2009 | US20090233957 (-)-beloxepin and methods for its synthesis and use |
| 09/17/2009 | US20090233953 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 09/17/2009 | US20090233947 2,3-Substituted fused bicyclic pyrimidin-4(3H)-ones which modulating the function of the vanilloid -1 receptor (VR1) |
| 09/17/2009 | US20090233945 New compounds 834 |
| 09/17/2009 | US20090233930 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia |
| 09/17/2009 | US20090233927 2-aminoquinolines |
| 09/17/2009 | US20090233918 2-(cyclic amino)-pyrimidone derivatives |
| 09/17/2009 | US20090233913 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 09/17/2009 | US20090233912 Non-aqueous pharmaceutical composition |
| 09/17/2009 | US20090233911 Thiadiazole derivatives for the treatment of neurodegenerative diseases |
| 09/17/2009 | US20090233910 Npy antagonists, preparation and uses |
| 09/17/2009 | US20090233906 Imidazoazepinone compounds |
| 09/17/2009 | US20090233904 Macrocyclic Spiro Pyrimidine Derivatives |
| 09/17/2009 | US20090233893 Methods of Dissolving Beta-Sheet Proteins and Uses Thereof |
| 09/17/2009 | US20090233878 Novel adenosine a3 receptor agonists |
| 09/17/2009 | US20090233872 Therapeutic Agent for Neurodegenerative Disease |
| 09/17/2009 | US20090233866 Screening Methods And The Use Of Agents Identified Using The Same |
| 09/17/2009 | US20090233862 Compositions and methods for treatment of optic nerve diseases |
| 09/17/2009 | US20090233841 Analgesic conjugates |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090233363 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/17/2009 | US20090232851 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 09/17/2009 | US20090232850 Therapeutic treatments using botulinum neurotoxin |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232779 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | CA2719097A1 Use of gabaa receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness |
| 09/17/2009 | CA2718463A1 Novel uses for 4-phenylbutyrate (4pba) and its pharmaceutically acceptable salts |
| 09/17/2009 | CA2718138A1 Azaindole compounds for treatment of central nervous system disorders |
| 09/17/2009 | CA2717322A1 Apoaequorin-containing compositions and methods of using same |
| 09/17/2009 | CA2716918A1 Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 09/17/2009 | CA2716907A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | CA2716764A1 Novel use of zinc n-acetyltaurinate |
| 09/17/2009 | CA2716079A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 09/17/2009 | CA2715110A1 Compounds for use in the treatment of neuropathic pain |
| 09/17/2009 | CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | CA2712609A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2710801A1 2-benzoyl-imidazo(1,2-.alpha) pyridine derivatives, their preparation and their therapeutic application |
| 09/17/2009 | CA2710797A1 Imidazo[1,2-.alpha.]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/16/2009 | EP2100902A1 Methods for treating pain by administering an antagonist antibody against the nerve growth factor and an opioid analgesic, and compositions containing the same |
| 09/16/2009 | EP2100901A1 Modified Insulin and conjugates thereof |
| 09/16/2009 | EP2100898A1 A process for concentration of a polypeptide |
| 09/16/2009 | EP2100895A1 Tricyclic compound and medical use thereof |
| 09/16/2009 | EP2100893A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 09/16/2009 | EP2100888A2 Process for the preparation of duloxetine hydrochloride |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
| 09/16/2009 | EP2100613A1 Chocolate and biscuit combination for uplifting the mood |
| 09/16/2009 | EP2099826A1 Method of providing disease-specific binding molecules and targets |
| 09/16/2009 | EP2099806A1 Spiropiperidine derivatives as nk3 antagonists |
| 09/16/2009 | EP2099784A2 1,5-diphenyl-3-pyridinylamino-1,5-dihydrioyrrolidin-2-ones as cb1 receptor modulators |
| 09/16/2009 | EP2099780A1 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders |
| 09/16/2009 | EP2099768A2 Agonists of the sphingosine-1-phosphate receptor |
| 09/16/2009 | EP2099766A1 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 09/16/2009 | EP2099763A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 09/16/2009 | EP2099476A1 Methods of treating alzheimer's disease |
| 09/16/2009 | EP2099464A2 Local administration of gallium compositions to treat pain |